A20 negatively regulates multiple inflammatory signalling pathways. We here addressed the role of A20 in club cells (also known as Clara cells) of the bronchial epithelium in their response to influenza A virus infection. Club cells provide a niche for influenza virus replication, but little is known about the functions of these cells in antiviral immunity. Using airway epithelial cell-specific A20 knockout (A20 Data Availability Statement: All relevant data are within the paper and its Supporting Information files.
Introduction
Disease outcome upon exposure to a certain pathogen relies on the capacity of the host to resist and tolerate the infection [1] . Resistance protects the host by suppressing pathogen replication and promoting clearance of the pathogen, a process that is mostly mediated by the innate and adaptive immune system. Tolerance refers to the ability to improve disease outcome without affecting pathogen burden and by limiting tissue damage. An overactive immune response can negatively impact on the disease by causing severe tissue damage [2] . Immunopathology is an important contributor to death during exposure to highly virulent strains of influenza A such as the 1918 H1N1 virus or highly pathogenic avian H5N1 and H7N1 viruses. The mechanisms contributing to immune pathology during flu virus infection have been well documented, and both innate and adaptive immunity seems to be involved [3] [4] [5] [6] . However, the exact molecular mechanisms regulating these processes are not well understood.
Detection of Influenza A by the innate immune system occurs by at least three different mechanisms [7] . Firstly, the cytosolic receptor RIG-I detects 5'-triphosporylated influenza virus genome segments [8, 9] . In the absence of the viral non-structural protein 1 (NS1), RIG-I induces a strong antiviral type-I interferon response [10] . Secondly, Toll-like receptors such as TLR3 and TLR7 detect virus-associated RNA molecules. TLR7 is mainly employed by IFN producing plasmacytoid dendritic cells, which produce large amounts of type-I IFN upon infection with influenza virus [11, 12] . TLR3, which recognizes double stranded RNA of yet undefined origin, has been shown to influence disease outcome following influenza virus infection [13] [14] [15] [16] . Thirdly, the NOD-like receptor family member NLRP3 senses multiple influenza virusassociated stimuli, including increased acidification of the cytoplasm mediated by the viroporin M2, leading to the activation of caspase 1 and the release of the cytokines interleukin-1β (IL-1β) and IL-18 [17] [18] [19] . A20 (TNF alpha-induced protein 3 or TNFAIP3) is a key player in the termination of inflammation, and has been shown to regulate these innate signalling pathways [19] [20] [21] [22] . We previously showed that A20 in macrophages critically suppresses influenza virus-induced innate immune responses and mice deficient in A20 in myeloid cells are protected against influenza A virus infection. This protective effect is mediated by an enhanced innate immune response and a better clearance of the virus [21] .
Epithelial cells of the respiratory epithelium are the primary target cells of human influenza viruses and main producers of infectious viral progeny [23] . Very little is known about the physiological contribution of these cells to antiviral immunity. Epithelial cells have long been considered as passive mediators in immunity, functioning primarily as physico-chemical barriers preventing invading pathogens from entering the submucosal layers or the respiratory system. It has become increasingly evident that epithelial cells also maintain important effector functions directing both innate and adaptive immunity crucial for efficient antiviral responses [24] . Respiratory epithelium actively contributes to pulmonary homeostasis [25] , immunity against viruses [26] and influenza induced immunopathology [27] . To study how A20 in epithelial cells influences influenza A disease progression, we generated mice lacking A20 specifically in bronchial epithelial cells (also known as club cells or Clara cells). We found that these mice are protected against influenza A virus infection. This protection does not result from an improved viral clearance or increased immune resistance to the virus, but correlates with a dampened pulmonary CTL response and a strongly suppressed expression of the chemokine CCL2 during later stages of infection.
Results

A20 regulates inflammatory responses in club cells of the airway epithelium
We studied the role of A20 in airway epithelial cells by crossing conditional A20 knockout mice (A20 FL/FL , S1A Fig) [28] with double transgenic animals carrying a reverse tetracycline transactivator controlled by the rat CCSP promoter (CCSP-rTA) and a Cre recombinase under control of the (TetO) 7 CMV operator [29, 30] . This generated A20 FL/FL /CCSP-rTA/(tetO) 7 -Cre triple transgenic offspring, hereafter referred to as A20 AEC-KO mice. Treatment of these mice with doxycycline enabled temporally controlled inactivation of the A20 gene specifically in club cells (also known as Clara cells) [31] , which constitute most of the epithelial cells found in the proximal airways of the mouse respiratory tract [32] . To ensure deletion of A20 in club cells at all times, breeding pairs and offspring were continuously maintained on a doxycycline diet. A20 AEC-KO mice were born at Mendelian ratios and displayed no developmental defects or signs of spontaneous pulmonary inflammation. Southern blot analysis on genomic DNA extracted from total lungs of A20 AEC-KO mice and control wild-type (A20 WT ) littermates showed Cre-mediated recombination of the A20 FL/FL allele only in lungs, but not in spleens, of A20 AEC-KO mice (S1B Fig). Since club cells represent a minor fraction of total lung tissue, only partial recombination was observed in total lung tissue from A20 AEC-KO mice. Semi-quantitative PCR analysis on genomic DNA isolated from various tissues of A20 AEC-KO mice, confirmed the deletion of A20 specifically in lung tissue (S1C Fig) . As A20 is expressed at low levels in most cell types including airway epithelial cells, we induced its expression by intratracheal instillation of LPS, a TLR4 agonist and known inducer of A20 in lung epithelium [33] . Analysis of A20 expression of Club cells purified from the lungs of A20 AEC-KO mice by Western blot showed the absence of A20 at the protein level (S1D A20 is a negative regulator of multiple signalling pathways induced by inflammatory stimuli including TNF and TLR ligands [34, 35] . We tested if A20 also regulates these pathways in club cells by intratracheal administration of TNF and poly(I:C), an agonist of the TLR3, RIG-I and MDA5 signalling receptors [36, 37] . We found increased numbers of neutrophils and monocytes recruited into the bronchoalveolar space of A20 AEC-KO mice compared to control littermates upon engagement of these receptors (Fig 1A and 1C) . Also significantly higher levels of IL-6, CXCL1 (KC), CCL2 (MCP-1), but not TNF were detected in the bronchoalveolar lavage (BAL) fluid of mice lacking A20 in club cells (Fig 1B and 1D ). These results demonstrate that A20 expression in club cells negatively controls inflammatory responses following exposure of the airway to TNF and poly(I:C). These data are in accordance with previously published results showing a similar regulatory role for A20 in various other cell types [34] .
A20 AEC-KO mice tolerate infections with influenza A virus
Since poly(I:C) is often used as a stimulus that mimics RNA virus infection, we next investigated the in vivo role of A20 in club cells in a mouse model of influenza A virus (IAV) infection. We used the H3N2 mouse adapted influenza A strain X-47 in most of the experiments [38] . Immunohistochemical staining of the club cell marker CCSP and the influenza A ion channel protein M2, revealed that X-47 infected CCSP expressing club cells, along with alveolar epithelial cells (S2A and S2B Fig) . This allowed us to directly study the in vivo role of A20 in the primary target cells of influenza A virus. A20 AEC-KO had a clear survival advantage compared to their control littermates following infection with a dose of X-47 virus that proved lethal for most wild type mice (Fig 2A) . Upon infection with a sublethal dose of X-47, A20 AEC-KO mice displayed less morbidity and weight loss at later stages (> 7 days) of infection ( Fig 2B) . Challenge with A/Puerto Rico/8/34 (PR8, H1N1 subtype) influenza virus confirmed the reduced susceptibility of A20 AEC-KO mice to IAV infection (S3 Fig) . This difference was also evident by histological analysis of lung tissue from X-47-infected mice ( Fig 2C and S4A  Fig) and by quantification of the total protein content in BAL fluid as a measure of lung damage and vascular leakage (Fig 2D) . We did not detect significant differences in viral titres in the lungs of A20 AEC-KO and A20 WT mice at day 2 and day 5 post-infection (Fig 2E) . These data indicate that the disease protection in A20 AEC-KO mice is likely not a consequence of an enhanced intrinsic capacity of A20 deficient club cells to inhibit viral replication. The levels of IFNα and IFNβ, cytokines with potent antiviral activity, and the IFN-inducible chemokine CXCL10, were comparable in BAL fluid isolated from A20 AEC-KO and A20 WT animals at AEC-KO and A20 WT mice at day 8 post infection ( Fig 2E) , which is the time during infection where both groups of mice differ in morbidity. Finally, since A20 is known to confer protection against cell death in multiple cell types (Catrysse et al., Trends Immunol., 2014), we assessed if A20 deficiency in club cells could sensitize these cells to apoptosis after IAV infection. In none of the assays performed, however, we could detect any significant difference in cell death between A20 AEC-KO lung samples and control samples (S5 Fig) .
The absence of A20 in club cells thus significantly improves disease outcome upon influenza A virus infection without altering viral clearance or type-I IFN responses. These data indicate that A20
AEC-KO mice are protected from influenza A virus infection by a mechanism that involves increased tolerance, rather than increased antiviral resistance. AEC-KO and control A20 AEC-WT littermates at different time points after sublethal IAV infection (n = between 3 and 11 for each time point). *p < 0.05; ***p<0.001. (E) Pulmonary viral titers determined by TCID 50 at 2, 5 and 8 days p.i. after infection with a sublethal dose (0.05 X LD 50 ) of X-47. Dashed line represents detection limit (ND = not detected). Data were pooled from 3 independent experiments and analyzed using Log-rank (A). Data are representative of at least 2 independent experiments and were analysed using 2-way ANOVA (B, *p < 0.05) or Student's t-test (C, ns = not significant) and are shown as mean ± SEM.
The pulmonary CTL response is dampened in A20 AEC-KO mice
The late onset (> 7 days) of protection to influenza A of A20 AEC-KO mice suggests that the effect is driven by the adaptive immune system. Although viral clearance and host survival critically depend on the recruitment of virus-specific CD8 + cytotoxic T cells (CTL) to the lung, influenza A-associated pulmonary immunopathology can be inflicted by an excessive antiviral CTL response. CTLs are major producers of TNF during influenza A virus infection which is known to contribute to immunopathology [5, 39, 40] . Analysis of CD8 + T cells by in vivo intracellular cytokine staining showed that A20 AEC-KO mice displayed reduced numbers of Granzyme B, IFNγ and TNF expressing activated (CD62L lo ) CD8 + T cells in the brochoalveolar space and to a lesser extend in the lung tissue at day 8 post infection with X-47 virus (Fig 3A  and 3B ). NP-pentamer staining of CD8 + T cells from the mediastinal lymph node, spleen and BAL revealed that there was no significant difference between control and A20 AEC-KO mice ( Fig 3C) . This suggests that the extent of influenza antigen-specific CD8 + T cell priming is comparable in the two mouse strains but that their activation in the lung compartment is different. A20 AEC-KO mice also showed reduced levels of IFNγ and TNF protein levels in the BAL fluid (Fig 3D) . Upon entering the lung, effector CD8 + T cells are programmed to produce high levels of the anti-inflammatory cytokine IL-10, which is an important mechanism to reduce immunopathology [41] . Measurements of IL-10 in BAL fluid showed that also IL-10 levels are lower in A20 AEC-KO mice (Fig 3D) . This indicates that the reduced CTL response in A20
AEC-KO mice is caused by a local signal from the pulmonary environment instead of a skewing of CD8 + T cells towards an anti-inflammatory phenotype.
A decreased CTL response can be the result of less effective priming of naïve T cells in the lung draining lymph nodes. Activated antigen-loaded dendritic cells travelling from the lung to the lung draining lymph nodes dictate the outcome of the CTL response [42] . However, we found no significant differences in the accumulation of CD11b -, CD11b + or inflammatory den- Loss of A20 in club cells did not affect antiviral humoral immunity as no significant differences in the levels of X-47 neutralizing antibodies were observed in sera from challenged A20
AEC-KO mice compared to wild-type mice (S6C Fig) .
Together, these data indicate that selective deletion of A20 in club cells suppresses the pulmonary CTL response against influenza A virus leading to a decreased production of cytotoxic CTL effector cytokines such as TNF.
CCL2 controls tolerance of A20 AEC-KO mice to influenza A infection
We next addressed whether A20 deficiency in club cells and associated suppression of pulmonary CTL responses affects the recruitment of innate immune cells to the lungs. The number of recruited monocytes, neutrophils and macrophages in BAL was measured at different time points after infection with X-47 virus. At late time points post-infection (> 5 days), the timing at which A20 AEC-KO mice show protection from influenza compared to control mice (Fig 2) , recruitment of monocytes and neutrophils was significantly lower in A20 AEC-KO compared to wild type mice (Fig 4A) . CD11b -macrophages ("resident" macrophages) constituted the predominant macrophage population in the lung parenchyma of unchallenged mice and at early time points post-infection, while the number of CD11b + macrophages ("recruited" macrophages) increased, starting around day 5 and peaking around day 8 post-infection (Fig 4B) . The lungs of A20 AEC-KO mice contained more CD11b -resident macrophages and alveolar macrophages compared to control littermates at peak CTL response, 8 days post-infection, and this difference sustained at later time points (Fig 4A and 4B) . Recruitment of macrophages to lungs is dependent on the chemokine CCL2 (MCP-1) [43] [44] [45] . In agreement with the elevated levels of recruited monocytes and macrophages at day 8 post-infection in control A20
WT mice, higher levels of CCL2 could be detected in BAL fluid of these mice compared to A20 AEC-KO littermates at this stage ( Figs 4C and S7A ). Other chemokines, such as KC (CXCL1) and Rantes (CCL5), were also differentially expressed in A20 AEC-KO and control A20 WT mice at day 8 post-infection, although at lower levels (S7A Fig). Immunohistochemical analysis of X-47-infected lung tissue confirmed enhanced CCL2 staining in CCSP + lung epithelial cells from A20 WT mice compared to A20 AEC-KO mice (S7B Fig) .
To assess the importance of reduced CCL2 levels in A20 AEC-KO mice for their protective phenotype upon influenza virus infection, we administered recombinant mouse CCL2 (rCCL2) to A20 AEC-KO mice at day 6 post-infection. In contrast to control (PBS) treated A20 AEC-KO mice, which again show protection from the virus challenge compared to wild-type littermates, rCCL2 treated A20 AEC-KO littermates mice are sensitized to infection and no longer show differences compared to PBS or cCCL2 treated wild-type mice (Fig 4D) . Together, these results show that the protection of A20 AEC-KO mice from infection results from a reduced CCL2-dependent recruitment of innate immune cells to the lungs of infected mice.
Discussion
A20 is an essential negative regulator of NF-κB signaling, and A20 deficient mice die prematurely due to massive multi-organ inflammation triggered by infiltrating intestinal bacteria [46, 47] . We showed in this study that specific deletion of A20 in respiratory epithelial cells protects mice from Influenza A virus-induced morbidity and lethality. Viral clearance and the production of the antiviral cytokines IFNα and IFNβ was similar in A20 AEC-KO and wild-type mice, in agreement with literature stating that epithelial cells are not the primary producers of type-I IFNs upon respiratory virus infection [48] . Interestingly, although the initial recruitment of innate cells and CTLs into the lungs of A20 AEC-KO mice was sufficient to clear the virus by 8 days post infection, monocyte recruitment and the local CTL response in the lung were markedly reduced during later stages of infection. This was rather surprising since A20 is characterized as a negative regulator of the antiviral immune response [49] . Indeed we could confirm such a role for A20 in a surrogate viral infection model using intratracheal instillation of the double stranded RNA mimic poly(I:C) showing hyperactive immune responses in AECspecific A20 knockout mice. Protection of A20 AEC-KO mice against influenza virus infection correlated with reduced recruitment of monocytes and CD11b + macrophages to the lungs. In line with this, the levels of the monocyte-recruiting chemokine CCL2 were much lower in lungs of A20 AEC-KO mice than in wild type mice on days eight and twelve after infection. It has been reported that administration of an MCP-1/CCL2 blocking antibody can reduce mortality and morbidity following influenza A virus infection [50] . Increased CCL2 levels have been reported in patients that had been infected with H7N9 virus [51] . CCL2 contributes to tissue immunopathology following influenza virus infection by its pro-inflammatory effects on macrophages and monocytes [52] . Recruitment of inflammatory macrophages in a manner dependent on the CCL2 receptor CCR2 contributes substantially to lung damage [53] . In line with this, we found that intranasal instillation of CCL2 in A20 AEC-KO mice rendered these mice as susceptible to disease caused by influenza A virus as wild type mice. In aggregate, the reduced levels of CCL2 in A20 AEC-KO mice could explain their increased tolerance to the infection. Yet after exposure of A20 AEC-KO mice to double stranded RNA, a surrogate viral PAMP, we observed increased levels of CCL2 compared to wild type controls. The latter observation is in line with the regulation of CCL2 expression by NF-κB [54] . So what caused the reduced levels of CCL2 in the A20 AEC-KO mice at later time points after influenza virus infection? It was remarkable that reduced disease, lower CCL2 levels and decreased CD8 + T cell activation coincided. CCL2 expression can be induced by IFNγ [55] . Therefore, the reduced numbers of IFNγ-producing CD8 + T cells could explain the lower CCL2 levels and monocyte infiltration in the A20 AEC-KO mice. Similarly trans-presentation of TNF by influenza HA specific CD8 + T cells to lung epithelial cells has been shown to induce strong expression of CCL2 leading to extensive lung injury due to infiltrating monocytes. Increased CCL2 release by club cells might in addition recruit monocytederived inflammatory dendritic cells into the lungs, which could sustain local CTL responses and inflicting further damage to the lung [56, 57] . Pro-inflammatory cytokine expression by club cells contributes to immunopathology during later stages of influenza infection [27] . Our study shows that expression of A20 in these cells might prevent lung damage by the host's immune system. The exact molecular mechanism of how the specific deletion of A20 in club cells leads to increased tolerance to influenza infection is not understood at this moment and is subject for future research.
In conclusion, these data show that loss of A20 in respiratory epithelium can protect mice following Influenza A virus infection. In agreement with previous results, showing that deletion of A20 in myeloid cells also protects from Influenza [21] , these data suggest that inhibiting A20 expression, for example by local administration of interfering RNAs, might be promising as a new therapeutic strategy to control disease caused by influenza A virus infection. 
Materials and Methods
Ethics statement
Mice
Conditional A20 knockout mice harbouring two LoxP sequences flanking exon 4 and exon 5 (A20 FL/FL ) were generated as previously described [28] and were crossed with CCSP-rTA/ (tetO) 7 -Cre mice to specifically delete A20 in airway epithelial cells (AEC) (provided by Dr. J. Whitsett, Cincinnati Children's Hospital, USA) [29, 58] . A20 FL/FL /CCSP-rTA/(tetO) 7 -Cre triple transgenic offspring were fed doxycycline-containing food pellets to delete A20 expression (625 mg/kg, Special Diet Services). All experiments were performed on age-and sex-matched littermates. All mice used in this study carried the A20 FL/FL and CCSP-rTA alleles. Those expressing the (TetO) 7 allele were termed A20 AEC-KO and those lacking this allele were considered as wild type controls (A20 WT ). Mice were housed in individually ventilated cages at the VIB-UGent Inflammation Research Center (IRC) in a specific pathogen-free animal facility.
Poly (I:C) and TNF administration
After anesthetisation, mice received an intratracheal dose of 50 μg low molecular weight endotoxin-free poly(I:C) (Invivogen) or 0.5 μg recombinant mouse TNF (in house production) in 50 μl PBS. Six or 24 h after instillation mice were sacrificed and broncheoalveolar lavages (BAL) were collected for flow cytometric analysis and cytokine / chemokine analysis.
Viruses
Mouse adapted influenza A X-47 (H3N2) and PR8 (H1N1) were propagated in MDCK (Madin-Darby canine kidney, ATCC) cells. After anesthetisation, mice were infected intranasally with X-47diluted in 50 μl PBS. For lethal and sublethal infections, mice received 2 X LD 50 X-47 and 0.05 X LD 50 X-47 or 0.17 X LD 50 PR/8, respectively. Mice were euthanized when weight loss exceeded 25% of the initial body weight. Recombinant mouse CCL2 (R&D Systems, endotoxin levels <0.01 EU per μg of protein as measured by the LAL method) was administered intranasally at a dose of 50 μg/kg at day 6 post infection. Pulmonary viral titres were determined by median tissue culture infectious dose (TCID 50 ) determination using MDCK cells. Lungs were homogenized in PBS using a Polytron homogenizer (Kinematica) and tenfold serial dilutions of cleared lung homogenates were incubated on MDCK cells in DMEM supplemented with trypsin (1 μg/ml), 2 mM L-glutamine, 0.4 mM sodium pyruvate and antibiotics. After 5 days, 0.5% chicken red blood cells (RBC) were added to cell culture supernatant and end-point dilution hemagglutination was monitored. TCID 50 titres were calculated according to the method of Reed and Muench [59] . HAI titres in serum of infected mice were determined as follows: serum was treated for 18 h at 37°C with receptor-destroying enzyme (RDE/Cholera filtrate, Sigma Aldrich) to remove sialic acids from serum proteins and prevent nonspecific inhibition of agglutination. RDE was then inactivated by the addition of 0.75% sodium citrate and heating at 56°C for 30 min. To remove sialic acid binding proteins, sera were cleared with 1/10 volume 50% chicken RBC. Titration was done by incubating a two-fold dilution series of sera with 4 HA units of X-47 for 1 h in 96-well U-bottom plate. An equal volume of 0.5% chicken RBC was then added and HAI titres were read after 30 min.
Club cell purification
The method for club cell isolation was adapted from [60] . Lungs were inflated with 0.25% trypsin/HBSS and incubated in DMEM at 37°C for 20 min. After trypsin neutralisation with FCS, lungs were cut into small 1 mm 3 sections and sequentially filtered without homogenisation through a 40 μm cell strainer. The cells were then placed into a humidified incubator at 37°C for 2 h to remove adherent cell populations (macrophages and fibroblasts). Club cells were specifically pelleted by centrifugation at 30 g for 8 min.
Flow cytometry
Lungs and mediastinal lymph nodes (MLN) were dissected into small 1 mm 3 sections and incubated with collagenase type IV (1 mg/ml, Worthington) and DNase I (100 U/ml, Roche) at 37°C for 30 min. Subsequently, samples were filtered and homogenised through a 40 μm cell strainer. For BAL, tracheas were cannulated and lungs were flushed 4 times with HBSS with 1 mM EDTA. The first ml was treated with EDTA-free protease inhibitor tablets (Roche) and frozen separately for cytokine/chemokine analysis. After treatment with red blood cell lysis buffer (Sigma Aldrich), cells were stained with monoclonal antibodies directed against MHC-II (I-A/I-E) (M5/114.15.2), CD11c (N418) CD8α (53-6.7), F4/80 (BM8), CD62L (MEL-14), Granzyme B (NGZB) B220 (RA3-6B2) from eBiosciences and CD45 (30-F11), CD3ε (500A2), Gr1 (RB6-8C5), Ly6G (1A8), Ly6C (AL-21) CD11c (HL3), CD11b (M1/70), CD4 (GK1.5), CD8α (53-6.7), IFNγ (XMG1.2), TNF (MP6-XT22) and CD16/32 (2.4G2) from BD Pharmingen. Samples were acquired on a LSRII Cytometer (BD Biosciences) and analysis was performed using FACSDiva software (BD Biosciences).
Immunohistochemistry
Lungs were inflated with 4% paraformaldehyde. After 1 hour lungs were washed in PBS and embedded in paraffin. 5 μm thick tissue sections were cut from paraffin blocks. For immunohistochemistry, sections were dewaxed, dehydrated and incubated in Dako antigen retrieval solution, brought to boiling temperature and allowed to cool down for 2 hours. Endogenous peroxidase activity was blocked by immersing slides in 3% H 2 O 2 for 5 min. Sections were blocked and permeabilized in 10% goat serum and 1% Triton X-100. Sections were incubated overnight at 4°C in blocking buffer with anti-M2 (in house preparation) and anti-CCSP (Abcam) antibody. Subsequently, slides were incubated with secondary antibody for 1 h (polymer HRP-labelled anti-mouse/rabbit/rat; Vector Laboratories) and peroxidase was detected by diaminobuteric acid (DAB) substrate (Sigma Aldrich). Tissue sections were counterstained with Mayer's haematoxylin, rehydrated and mounted in Pertex mounting medium (Histolab). For A20 staining, sections were incubated for 60 min at 4°C in blocking buffer with anti-A20 (ProSci) antibody, and subsequently with HRP-labeled anti-rabbit IgG and FITC-labeled anti-HRP. For CCL2/MCP1 staining, sections were incubated for 30 min with anti-CCL2 (Abcam, clone ECE.2) antibody, followed by Cy3-labeled anti-rat antibody.
In vitro and in vivo intracellular staining of activated T cells
For in vitro peptide stimulation, 5 x 10 6 cells isolated from spleen or lungs of animals infected with X-47 were stimulated with different concentrations of NP-peptide (ASNENMETM, JPT peptide solutions). After 18h, brefeldin A was added to the cell culture and after 6 h cells were collected and stained for cell surface markers and IFNγ. In vivo intracellular staining for GrB, IFNγ and TNF from freshly isolated BAL and lungs was performed as described previously [61] . Mice were treated intranasally with 50 μg brefeldin A (Sigma Aldrich) 6 h before tissue collection and single cell suspensions from BAL and lungs were prepared in the presence of 3 μg/ml brefeldin A. Cells were stained for cell surface markers and intracellular molecules and fixed and permeabilized in Cytofix / Cytoperm (BD biosciences) according to manufacturer's instructions. Activated CD8 + T cells were identified as CD3ε + , CD8α + and CD62L lo . Live/ Dead fixable aqua dead cell stain (Molecular Probes) was used to discriminate live from dead cells. 
Pentamer staining
Cytokine quantification
Detection of CCL2 (MCP-1), CCL5 (Rantes), CXCL1 (KC), IL-6 and TNF in BAL fluid was performed using Multiplex immunoassay technology (BioRad). IFNγ, IL-10 (eBioscience) IFNβ and IFNα (R&D Systems and Invivogen) protein levels were determined by ELISA.
Western, Southern blotting and genomic PCR
For Western blotting, cells were lysed at 4°C for 15 min in lysis buffer (200 mM NaCl, 1% NP-40, 10 mM Tris-HCl pH 7.5, 5 mM EDTA and 2 mM DTT) supplemented with protease and phosphatase inhibitors. Cell lysates were subsequently separated by SDS-PAGE and analyzed by western blotting and ECL detection (Perkin Elmer Life Sciences). Immunoblots were revealed with anti-A20 (Santa Cruz), anti-actin (MP Biomedicals) and HRP-linked anti-mouse (GE Healthcare) antibodies. For Southern blotting, genomic DNA was digested with BamHI yielding 6.5-and 13.5-kb fragments for A20 floxed and deleted alleles, respectively. DNA was separated on an agarose gel and transferred to a nitrocellulose membrane. Hybridization was performed with a 32 P-labeled probe. A20 specific genomic PCR was performed using the following primers: 5'-CAC AGA GCC TCA GTA TCA TGT-3', 5'-CCT GTC AAC ATC TCA GAA GG-3' and 5' GCA GCT GGA ATC TCT GAA ATC 3'.
Cell death measurement
Apoptosis was analysed by fluorescence microscopy using an in situ cell death detection kit (Roche). Caspase activity was measured by incubation of 25 μg tissue homogenate with 50 μM acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-amc) (Peptide Institute, Osaka, Japan) in 150 μl cell-free system buffer (10 mM HEPES-NaOH pH 7.4, 220 mM mannitol, 68 mM sucrose, 2 mM NaCl, 2.5 mM KH 2 PO 4 , 0.5 mM EGTA, 2 mM MgCl 2 , 5 mM pyruvate, 0.1 mM PMSF, 1 mM dithiothreitol). The release of fluorescent 7-amino-4-methylcoumarin was measured for 50 min at 2-min intervals by fluorospectrometry at 360 nm excitation and 480 nm emission wavelength, using a Cytofluor device (PerSeptive Biosystems, Cambridge, MA). The maximal rate of increase in fluorescence was calculated (Δfluorescence/min). Lungs were prepared as described for flow cytometric analysis and cells were stained with antibodies directed against CD326 (EpCAM, eBioscience clone G8.8), CD45 and CD31 (eBioscience, clone 390). Prior to flow cytometric analysis cells were washed and incubated with Annexin V and propidium iodide in Annexin V binding buffer according to manufacturer's instructions (BD Biosciences).
Statistics
Data were analysed using GraphPad Prism Software. Results are expressed as the mean ± SEM. Statistical significance between experimental groups was assessed using an unpaired two-sample Student's t test. Statistical significance of differences between survival rates was analysed by comparing Kaplan-Meier curves using the log-rank test.
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